Frequently Asked Questions




  • Dental practice potential patient exposure letter (English) (Spanish)
  • Medical practice potential patient exposure letter (English) (Spanish)









Delay in Printing of Licenses.

Due to COVID-19, we are experiencing a delay in the printing of licenses. All licensee status and expiration dates can be verified at

Licensing-Related Information

Dental health professionals must apply for and renew their licenses with the Department of Health. The Rhode Island Board of Examiners in Dentistry ensures that all dentists and dental hygienists practicing in Rhode Island meet the requirements for licensure and comply with the applicable conditions and regulations of the law.

Continuing Education/Training

Continuing Education Opportunities for Dental Professionals

Professional Resources

Pain Management

  • Managing Pain After Dental Surgery
  • Naloxone

    Screen all patients and caregivers.

    • Check a patient’s electronic health record (EHR) and ask the patient about previous naloxone use.
    • Check Rhode Island’s Prescription Drug Monitoring Program (PDMP) for clinical alerts and evidence of high-dose opioids (i.e., more than 50 oral Morphine Milligram Equivalents (MMEs) per day), long-acting opioid use, or opioid use for longer than 90 days.
    • Screen all patients for a history or diagnosis of Substance Use Disorder (SUD), Alcohol Use Disorder (AUD), mental health conditions, respiratory or neurologic conditions that affect breathing, harmful use or misuse of opioids, and/or opioid overdose.
    • Screen patients for use of Medication Assisted Treatment (MAT) to treat OUD.
    • Screen all patients to identify use of opioids in combination with benzodiazepines, alcohol, anti-depressants, and/or sedatives.

    Educate yourself, patients, and staff.

    • Ask caregivers if they feel comfortable administering naloxone during an overdose in case a friend or loved one is experiencing a bad reaction to an opioid.
    • Tell patients who are taking opioids about the potential for bad reactions that make breathing slow down or stop, leading to an overdose.
    • Emphasize to patients that naloxone is an antidote and can save a life, just like a seatbelt or fire extinguisher.
    • Tell patients and caregivers about what to expect after giving someone naloxone.
    • Include a conversation about the importance of having naloxone on-hand as a standard part of opioid safety messages.
    • Ensure all office staff know where to locate and how to use naloxone in case of an overdose.
    • Review the signs and symptoms of opioid overdose and the legal protections under Rhode Island’s Good Samaritan Law.
    • Sign and display these pledges on opioid safety.
    • Print, hang, and distribute educational materials about naloxone.

    Promote increased access to naloxone.

    • Join the US Surgeon General and be a role model. Purchase and carry naloxone. Incorporate naloxone co-prescribing in EHRs, office protocols, and electronic prescribing systems.
    • Co-prescribe naloxone to patients who are currently being prescribed syringes and needles.
    • Stock naloxone in the office for emergency use and for direct dispensing to patients.
    • Remind patients and staff that pharmacists can dispense naloxone and bill insurance companies without a prescription from a healthcare provider.
    • If cost is a barrier for patients, help them enroll in a health insurance plan.
  • Prescription Drug Monitoring Program
  • Safe Opioid Prescribing

Safe Practice

Record Keeping

Board Information

Board of Examiners in Dentistry

Recently Submitted Meeting Minutes